Loading Page
Dr. Brian J. Shayota, MPH, MD is a genetics specialist in Salt Lake City, UT specializing in genetics and clinical biochemical genetics. He graduated from St. George's University School of Medicine in 2014 and has 12 years of experience. Dr. Brian J. Shayota, MPH, MD is affiliated with University of Utah Health and OU Health.
Dr. Brian J. Shayota, MPH, MD graduated from St. George's University School of Medicine in 2014. He completed residency at New York Medical College Affiliated Hospitals. He is certified by the American Board of Medical Genetics (Medical Biochemical Genetics) and has a state license in Oklahoma.
Medical School: St. George's University School of Medicine (2014)
Residency: New York Medical College Affiliated Hospitals (2017)
Board Certification: American Board of Medical Genetics (Medical Biochemical Genetics)
Licensed In: Oklahoma
Dr. Brian J. Shayota, MPH, MD does not have any reviews yet, be the first to leave a review of Dr. Brian J. Shayota, MPH, MD here: Leave a Review
These charts describe general payments received by Dr. Brian J. Shayota, MPH, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$31,983
ELFABRIO $27,806 |
LAMZEDE $4,177 |
|||||
|
$28,353
CERDELGA $48 |
$28,305 |
|||||
|
$15,675
Ravicti $15,675 |
||||||
|
$7,967
OPFOLDA $7,891 |
$76 |
|||||
|
$4,227
$4,227 |
||||||
|
$4,154
AQNEURSA $106 |
Kuvan $81 |
Palynziq $50 |
PEDIARIX $44 |
DOJOLVI $30 |
Other $3,843 |
| $34,234 | |
| $23,027 | |
| $15,821 | |
| $15,619 | |
| $3,509 | |
| $150 |
Dr. Brian J. Shayota, MPH, MD has received 37 research payments totaling $293,262.
Brian J. Shayota, MD, MPH, is an Assistant Professor of Pediatrics and Medical Genetics at University of Utah Health and Primary Children's Hospital. Dr. Shayota is Director of Metabolic Services, Director of Telegenetics Consultation Services for Level III NICUs across Utah, and Director of the ReSeq clinic. Shayota specializes in biochemical and clinical genetics, caring for patients with inborn errors of metabolism, reviews newborn screening for Utah, Nevada, and Alaska, and serves as primary investigator on clinical trials of novel genetic therapies.
